Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on recent advances in pediatric vasculitis.
Pediatric vasculitis has seen significant advancements in recent years, particularly in understanding the role of genetics and the immune system. Researchers have identified genetic factors linked to the susceptibility of certain vasculitis types, such as Kawasaki disease, improving early diagnosis and personalized treatment.
In treatment, biologic therapies, especially those targeting specific immune pathways like TNF inhibitors and IL-1 blockers, have shown promise in managing vasculitis more effectively. These treatments provide new options for patients unresponsive to conventional therapies.
Another breakthrough is the development of non-invasive imaging techniques, such as advanced MRI and PET scans, which allow for better monitoring of disease activity and response to therapy, reducing the need for invasive procedures like biopsies.
Collaborative efforts through global registries and research networks are also helping to gather more data on pediatric vasculitis. This has led to more standardized diagnostic criteria and treatment protocols, enhancing outcomes for young patients.
Lastly, improved awareness and education among healthcare providers have resulted in earlier recognition and intervention, preventing long-term complications. This progress represents a hopeful outlook for managing pediatric vasculitis in the coming years.
Therefore, get an overall knowledge of recent advances in pediatric vasculitis. Lis
See More Webinars @ Hidoc Webinars
1.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
2.
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer
3.
A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.
4.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
5.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
1.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
2.
Oncology Communication Simulation: Enhancing Clinical Competence Through Evidence-Based Training
3.
Drug Safety Monitoring of Delayed Hematologic Effects After Prolonged Medication Exposure
4.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
5.
New Research on Craniopharyngioma
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Understanding the Importance of Follow-Up After Cancer Treatment
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation